Aaron Hoffman
Corporate Officer/Principal at Technion-Israel Institute of Technology
Profile
Dr. Aaron Hoffman, MD, is a Director & Chief Medical Officer at PerAssist Ltd.
and an Associate Professor at Technion-Israel Institute of Technology.
He is on the Board of Directors at PerAssist Ltd.
Dr. Hoffman was previously employed as a Director-Vascular Surgery & Transplantation by Rambam Medical Center, a Member by Israeli Ministry of Health, and a Member by Ministry of Defense.
He received his doctorate degree from The Hebrew University of Jerusalem.
Aaron Hoffman active positions
Companies | Position | Start |
---|---|---|
Technion-Israel Institute of Technology | Corporate Officer/Principal | 2011-02-28 |
Former positions of Aaron Hoffman
Companies | Position | End |
---|---|---|
Israel Ministry of Defense | Corporate Officer/Principal | - |
Rambam Medical Center | Corporate Officer/Principal | - |
Israel Ministry of Health | Corporate Officer/Principal | - |
PerAssist Ltd.
PerAssist Ltd. Medical SpecialtiesHealth Technology PerAssist Ltd. developed devices to improve blood flow. The firm developed Peri-Boost, a device that offers a viable treatment option for patients facing lower limb amputation due to complications of advanced peripheral artery disease (PAD) patients who are not candidates for angioplasty, atherectomy, or bypass. It has the potential to dramatically reduce the rising number of PVD patients who undergo lower limb amputation due to the inadequate treatment options available. The company was founded by Gaby Weizman and Aaron Hoffman and is headquartered in D.N. Misgav, Israel. | Founder | - |
Training of Aaron Hoffman
The Hebrew University of Jerusalem | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
PerAssist Ltd.
PerAssist Ltd. Medical SpecialtiesHealth Technology PerAssist Ltd. developed devices to improve blood flow. The firm developed Peri-Boost, a device that offers a viable treatment option for patients facing lower limb amputation due to complications of advanced peripheral artery disease (PAD) patients who are not candidates for angioplasty, atherectomy, or bypass. It has the potential to dramatically reduce the rising number of PVD patients who undergo lower limb amputation due to the inadequate treatment options available. The company was founded by Gaby Weizman and Aaron Hoffman and is headquartered in D.N. Misgav, Israel. | Health Technology |
Rambam Medical Center | |
Israel Ministry of Health | Government |
Israel Ministry of Defense | Government |
- Stock Market
- Insiders
- Aaron Hoffman